The present methodology in the diagnosis of vasovagal syncope (WS) is
based on the clinical evaluation of the course of syncope during the p
assive, positive head-up tilt test. The clinical division is based on
result analysis of heart rate and blood pressure change during first p
assive test and second with vagal nerve inhibition via atropine. Class
ification not involving drugs is a division according to the Vasovagal
International Study (VASIS). Some research centers, aiming to verify,
their diagnosis, employ an evaluation of heart rate variability (HRV)
spectrum intensity or a provocative pharmacological test. The goal of
our research was to evaluate the type of syncope according to clinica
l standards as well as VASIS and verify these results with the help of
HRV analysis. The data of 24 patients (pts) aged 15 to 69 yrs (avg. 3
2.8 17.4; 13M, 11F) with clinically diagnosed WS: vasodepressive (VD)-
5, cardioinhibitory (CI)-4, mixed (MX)-15 was analyzed, and in 12 of t
hem HRV analysis was possible. In 20 pts (83.3%) the clinically obtain
ed syncope type correlated with the VASIS classification. The HRV inte
nsity shaped itself as follows: increase of spectrum intensity in the
low frequency (LF) and high frequency (HF) range: type VASIS-2 or VASI
S-1, decrease in LF and HF: type VASIS-3 or VASIS-1, decrease in LF, i
ncrease in HF: type VASIS-1. Conclusion: I)The VASIS classification co
rresponds in 83.3% with the standard clinical protocol in differentiat
ing syncope types. 2) It defines cardioinhibitory type (2A, 2B) more p
recisely, which allows for better evaluation of vessel activity. 3) On
the basis of the obtained heterogeneous HRV analysis results, it seem
s necessary to broaden the classification of VASIS-1 type into type IA
(vasodepressive-like), IB (cardioinhibitory-like) and IC (pure-mixed)
.